U.S. Water Utilities Stock News

ONEOK (OKE) recently announced a joint venture with WhiteWater, MPLX, and Enbridge to construct the Eiger Express Pipeline, enhancing its strategic initiatives in natural gas transportation. Over the past week, the company's stock price moved 2.5%, which aligns with a generally mixed market performance, as major indexes were mixed with slight declines or gains. While the overall market had a flat week, ONEOK's involvement in this pipeline project and potential benefits from increased...

As the U.S. stock market navigates a mixed landscape, with recent rallies and shifts in major indices like the Dow Jones Industrial Average and S&P 500, investors are closely watching for opportunities amidst potential interest rate cuts and strong corporate earnings. In this environment, identifying undervalued stocks becomes crucial as they may offer significant growth potential when market conditions stabilize or improve.

As the U.S. stock market navigates a mixed landscape with major indices showing varied performances, investor optimism is buoyed by potential interest rate cuts and robust corporate earnings reports. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal strong confidence from those closest to the business, which can be crucial during times of economic uncertainty.

As the U.S. stock market navigates a mixed landscape, with major indices showing varied performances and investor attention focused on potential interest rate cuts, opportunities continue to emerge for those looking beyond the mainstream. Penny stocks, while often seen as remnants of past market eras, still hold promise for investors seeking affordability combined with growth potential. By honing in on companies with strong financials and clear growth paths, these smaller or newer entities...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

If you have been watching Navigator Holdings (NVGS) lately, the company’s recent quarterly earnings and aggressive share repurchase may have caught your eye. On top of posting another profitable quarter, Navigator completed a nearly 5% buyback. This sends a clear signal that management sees value in the stock and remains committed to rewarding shareholders. With a freshly affirmed dividend added to the mix, it is easy to understand why investor attention is turning toward NVGS this...

Diodes (DIOD) just made waves with the launch of four new automotive-grade asynchronous buck converters aimed at 48V point-of-load applications. These compact devices are built to handle everything from motor control to advanced driver assistance systems across the full automotive battery range. The technical improvements, such as fast transient response, advanced protection features, and noise reduction, are designed to meet pressing industry demands for more reliable and simplified power...

Recent updates reveal that Rockwell Automation has experienced no organic revenue growth over the past two years, alongside decreasing earnings per share and returns on capital. This shift in fundamentals highlights rising investor concerns about the company's ability to sustain its historical growth and profitability levels. We'll explore how the absence of organic growth and profitability challenges may influence Rockwell Automation's investment outlook. Trump's oil boom is here -...

When Cimpress (CMPR) released a softer earnings report last week, many might have expected its shares to struggle, at least in the short term. Yet the stock held firm, drawing investor attention to underlying signals beyond the headline numbers. The company’s accrual ratio, sitting at -0.16, points to robust free cash flow and suggests statutory profit may actually be underplaying Cimpress’s true earnings power. Still, the dip in free cash flow compared to last year cannot be ignored and...

If you’ve been keeping an eye on WaFd (WAFD), the recent surge in its stock price might have given you a reason to pause and wonder what’s behind the rally. Two main factors have investors buzzing: first, Federal Reserve Chair Jerome Powell’s unexpectedly dovish remarks at the Jackson Hole symposium, which hinted at the possibility of lower interest rates ahead. Second, WaFd has just turned in a quarterly earnings report that checked many boxes by beating expectations on revenue, earnings per...

If you have been watching Prosperity Bancshares (PB), the recent rebound in the stock might be catching your eye. The trigger came from upbeat comments by Fed Chair Jerome Powell at the Jackson Hole symposium, where he hinted at a potential shift toward lower interest rates. This change in sentiment gave regional banks like Prosperity Bancshares a welcome boost, especially after months of navigating headwinds from stubbornly high rates. Add in solid earnings and a growing presence in Texas...

Popular (BPOP) just gave its shareholders a reason to pay attention. The Board of Directors has approved a quarterly cash dividend of $0.75 per share, payable this October. While dividend hikes might seem like routine fare for some companies, these moves often signal management's confidence in the business and its underlying earnings power. For investors wondering about Popular’s momentum, this dividend decision is a clear indication that the bank is focused on rewarding shareholders and...

Akero Therapeutics (AKRO) just revealed the final 96-week results from its Phase 2b HARMONY trial for efruxifermin, an investigational therapy for people living with MASH and significant liver fibrosis. The data, published in The Lancet, showed sustained improvements in fibrosis and markers of metabolic health. This is a meaningful milestone for patients and investors alike. Given the complexity of MASH and the unmet need for new treatments, this clinical update is likely to influence how the...

If you are tracking PJT Partners (PJT), this week’s headlines about record-breaking fund ABS issuance probably caught your eye. The company has highlighted a surge in asset-backed securities activity this year, noting how more asset managers are tapping into this corner of the fund finance world. As an adviser closely connected to these trends, PJT now finds itself in the spotlight, raising new questions about its potential to capture value from these evolving market dynamics. The share price...

Wyndham Hotels & Resorts (WH) has just debuted the redesigned Comwell Hvide Hus Aalborg, a 16-story landmark now operating under the Dolce by Wyndham brand in Denmark. This is not just any hotel update. It marks Wyndham’s fourth partnership with Comwell in Denmark and it arrives at a time when travelers are seeking authentic, experience-focused stays. From new signature dining concepts to flexible meeting spaces, the move aligns closely with current travel trends, and it shows that Wyndham is...

Marzetti (MZTI) grabbed the spotlight after its latest quarterly earnings, and for good reason. The company just posted record sales, growing both revenue and volume thanks to a stronger retail segment and successful licensing partnerships. However, the bottom line told a different story, as cost increases and restructuring expenses cut into profits. Operating margins also came in softer than hoped. Investors are now weighing the uptick in demand and fresh product launches against the...

If you have been following Federated Hermes (FHI), you have seen the latest surge in interest across the investment management industry. Sector-wide momentum is building behind growing assets under management and a new wave of institutional inflows. Federated Hermes is riding these tailwinds, thanks in part to its focus on technology and its willingness to expand into new, innovative products. These moves catch the attention of investors looking for long-term growth stories in a rapidly...

LivaNova (LIVN) is making headlines this week after announcing the commercial launch of its Essenz Perfusion System in China, following recent local regulatory approval. For investors, this move represents more than just a product expansion, as it positions LivaNova to enter the world’s second-largest market for heart-lung machines. With China’s extensive cardiac surgery needs and a technology-driven system co-developed with clinicians, this milestone could serve as a meaningful catalyst for...

Recent forecasts indicate that Employers Holdings is expected to face a 1.8% revenue decline over the next 12 months, along with reduced profitability from incremental sales and falling earnings per share. This outlook points to potential challenges for the company’s workers’ compensation insurance business and signals rising investor caution regarding its future earnings. We’ll examine how expectations for declining revenue and earnings may reshape Employers Holdings’ investment narrative...

EastGroup Properties (NYSE:EGP) just delivered news that will matter to anyone considering their options with the stock at this time. The company’s Board announced a 10.7% increase to its quarterly dividend, raising the payout to $1.55 per share. This represents more than just a strong quarter; it marks the 183rd consecutive quarterly cash distribution, reflecting a streak of dividend consistency and growth over 33 years. Actions like this can signal management’s confidence in the company’s...

Plexus (PLXS) just delivered an upbeat third-quarter report, catching the eye of investors with adjusted earnings per share outpacing expectations. The real story comes from broad revenue growth and a wave of new business. The company secured 41 manufacturing programs, which could potentially bring in an extra $250 million per year once they are fully operational. Additionally, Plexus management expressed optimism for the next quarter, projecting not only higher revenues but also improved...

If you’ve been eyeing NewAmsterdam Pharma (NasdaqGM:NAMS), the latest developments could make you pause and reassess next steps. This week, the company unveiled a dedicated oral solid dosage manufacturing suite in partnership with Piramal Pharma Solutions. This multi-million-dollar move is aimed at boosting production efficiency for its investigational fixed dose combination of obicetrapib and ezetimibe. The timing matters, as the facility is built to handle potential high demand if...

RXO (RXO) investors have a new curveball to consider. Johnson Fistel, PLLP has announced an investigation into whether the company or its top executives might have failed to disclose important information. This raises the possibility of federal securities law violations. For anyone holding RXO stock, this development could signal a shift in the risk profile, as legal scrutiny often prompts investors to reassess what they think they know about a company’s prospects. This latest legal spotlight...